Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer Meeting Abstract


Authors: Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; Bajorin, D. F.
Abstract Title: Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer
Meeting Title: 2015 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 7 Suppl.
Meeting Dates: 2015 Feb 26-28
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-03-01
Language: English
ACCESSION: WOS:000356886700322
PROVIDER: wos
DOI: 10.1200/jco.2015.33.7_suppl.322
Notes: Meeting Abstract: 322 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    658 Bajorin
  2. Scott R Gerst
    48 Gerst
  3. Wassim Abida
    156 Abida
  4. Ashley Regazzi
    89 Regazzi
  5. Jonathan Eric Rosenberg
    511 Rosenberg
  6. Mariel Elena Boyd
    12 Boyd
  7. Asia S McCoy
    19 McCoy